These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1876671)

  • 1. Naloxone blockade of amphetamine place preference conditioning.
    Trujillo KA; Belluzzi JD; Stein L
    Psychopharmacology (Berl); 1991; 104(2):265-74. PubMed ID: 1876671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes.
    Agmo A; Federman I; Navarro V; Padua M; Velazquez G
    Pharmacol Biochem Behav; 1993 Sep; 46(1):183-94. PubMed ID: 8255911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug reinforcement studied by the use of place conditioning in rat.
    Mucha RF; van der Kooy D; O'Shaughnessy M; Bucenieks P
    Brain Res; 1982 Jul; 243(1):91-105. PubMed ID: 6288174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1990; 102(2):263-8. PubMed ID: 2274609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazolam attenuates amphetamine but not morphine conditioned place preferences.
    Pettit HO; Batsell WR; Mueller K
    Psychopharmacology (Berl); 1989; 98(4):483-6. PubMed ID: 2505288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate reinforcement and naloxone aversion, as revealed by place preference paradigm, in two strains of rats.
    Dymshitz J; Lieblich I
    Psychopharmacology (Berl); 1987; 92(4):473-7. PubMed ID: 3114801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.
    Mackey WB; van der Kooy D
    Pharmacol Biochem Behav; 1985 Jan; 22(1):101-5. PubMed ID: 2858106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat.
    Skoubis PD; Maidment NT
    Neuroscience; 2003; 119(1):241-9. PubMed ID: 12763085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.
    Mucha RF; Iversen SD
    Psychopharmacology (Berl); 1984; 82(3):241-7. PubMed ID: 6425908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation rearing prevents the reinforcing properties of amphetamine in a conditioned place preference paradigm.
    Wongwitdecha N; Marsden CA
    Eur J Pharmacol; 1995 Jun; 279(1):99-103. PubMed ID: 7556389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.
    Carboni E; Acquas E; Leone P; Di Chiara G
    Psychopharmacology (Berl); 1989; 97(2):175-8. PubMed ID: 2498925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rewarding properties of some drugs studied by place preference conditioning.
    Biała G; Langwiński R
    Pol J Pharmacol; 1996; 48(4):425-30. PubMed ID: 9112683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists.
    Acquas E; Carboni E; Garau L; Di Chiara G
    Psychopharmacology (Berl); 1990; 100(4):459-63. PubMed ID: 2320706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice.
    Wu WR; Zhu XZ
    Eur J Pharmacol; 1999 Jan; 364(1):1-6. PubMed ID: 9920178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivational effects of opioids: evidence on the role of endorphins in mediating reward or aversion.
    Stolerman IP
    Pharmacol Biochem Behav; 1985 Nov; 23(5):877-81. PubMed ID: 3909169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rewarding properties of beta-endorphin as measured by conditioned place preference.
    Amalric M; Cline EJ; Martinez JL; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1987; 91(1):14-9. PubMed ID: 2950541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reward and reinforcement produced by drinking sucrose: two processes that may depend on different neurotransmitters.
    Agmo A; Galvan A; Talamantes B
    Pharmacol Biochem Behav; 1995 Oct; 52(2):403-14. PubMed ID: 8577808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.